As the race to deliver personalised engagement at scale heats up, artificial intelligence (AI) has become the critical ...

I have long held the belief that digital therapeutics will be prescribed alongside drugs to improve patient outcomes, leading ...

Zealand Pharma AS (ZLDPF) showcases promising trial results and strategic partnerships while navigating high R&D expenses and ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third quarter 2024 investor ...

Keay Nakae’s rating is based on several strategic and financial factors that position Alnylam Pharma favorably in the market. The company has demonstrated robust quarterly performance with a 34% ...

Laser Photonics Corporation has acquired Control Micro Systems to expand its market reach into the pharmaceutical industry, leveraging CMS’s precision laser solutions for controlled-release ...

With a mix of breakout sessions, hands-on workshops, and in-depth discussions, learning from real-world case studies that ...

AI-Driven Platform and Strategic Acquisitions to Drive Health & Wellness Growth and Profitability TORONTO, ON / ACCESSWIRE / November 5, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP ...

TORONTO, ON / ACCESSWIRE / November 5, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) has outlined a five-year roadmap focused on expanding revenue streams and brand presence through a targeted ...

POTOMAC, MD / ACCESSWIRE / November 6, 2024 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") is pleased to announce the publication of a new interview with CEO Ram Mukunda ...

Experts in the neuropsychiatry drug development space say targeting the right patient population will be key for success in ...

In the interview, Ram Mukunda discusses IGC's strategic expansion into metabolic and neurological markets, specifically addressing the potential of GLP-1 agonists in both Alzheimer's and weight loss ...